| Financial Year |
March 31 2023 |
| Monetary Funds |
189,860,443.37 |
| Held-for-trading Financial Assets |
439,166,501.48 |
| Notes Receivable |
8,851,171.13 |
| Accounts Receivable |
223,307,741.88 |
| Advances to Suppliers |
6,521,353.03 |
| Other Receivables |
9,387,547.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
194,208,176.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
20,000,000.00 |
| Other Current Assets |
18,323,639.42 |
| Total Current Assets |
1,172,152,794.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
41,227,095.27 |
| Investment Properties |
-- |
| Fixed Assetes |
735,036,627.73 |
| Under-construction Projects |
478,902,633.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
61,275,952.47 |
| R&D expenses |
-- |
| Goodwill |
9,690,756.41 |
| Long-Term Deferred and Prepaid Expenses |
7,239,485.41 |
| Deferred Income Tax Assets |
34,309,439.19 |
| Other Non-Current Assets |
49,387,718.50 |
| Sub-Total of Non-Current Assets |
1,508,510,997.13 |
| Total Assets |
2,680,663,791.37 |
| Short-Term Loans |
341,467,647.50 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
79,141,472.76 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,889,342.30 |
| Taxes Payable |
3,443,242.46 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
72,463,435.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
161,797,215.70 |
| Other Current Liabilities |
2,252,740.31 |
| Sub-Total of Current Liabilities |
669,880,990.40 |
| Long-term Loans |
556,903,592.95 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
38,669.84 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
620,552,272.36 |
| Total Liabilities |
1,290,433,262.76 |
| Paid-In Capital(Or Share Stock) |
277,303,421.00 |
| Capital Surplus |
685,366,666.12 |
| Surplus Reserve |
68,516,813.84 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
416,023,183.68 |
| Minority Stockholder's Interest |
20,488,380.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,369,742,148.03 |
| Owner's Equity（Stockholder's Equity） |
1,390,230,528.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,680,663,791.37 |
